Skip to Content
MilliporeSigma
  • Pyrophosphate therapy prevents trauma-induced calcification in the mouse model of neurogenic heterotopic ossification.

Pyrophosphate therapy prevents trauma-induced calcification in the mouse model of neurogenic heterotopic ossification.

Journal of cellular and molecular medicine (2020-09-05)
Natália Tőkési, Eszter Kozák, Krisztina Fülöp, Dóra Dedinszki, Nikolett Hegedűs, Bálint Király, Krisztián Szigeti, Kitti Ajtay, Zoltán Jakus, Jeremy Zaworski, Emmanuel Letavernier, Viola Pomozi, András Váradi
ABSTRACT

Trauma-induced calcification is the pathological consequence of complex injuries which often affect the central nervous system and other parts of the body simultaneously. We demonstrated by an animal model recapitulating the calcification of the above condition that adrenaline transmits the stress signal of brain injury to the calcifying tissues. We have also found that although the level of plasma pyrophosphate, the endogenous inhibitor of calcification, was normal in calcifying animals, it could not counteract the acute calcification. However, externally added pyrophosphate inhibited calcification even when it was administered after the complex injuries. Our finding suggests a potentially powerful clinical intervention of calcification triggered by polytrauma injuries which has no effective treatment.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Yohimbine hydrochloride, ≥98% (HPLC), powder
Sigma-Aldrich
(±)-Propranolol hydrochloride, ≥99% (TLC), powder
Sigma-Aldrich
Prazosin hydrochloride, ≥99.0% (HPLC)